Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regulatory Lymphocytes (Treg) in the Modulation of Allergic Inflammation in Patients Treated With Specific Immunotherapy.

NCT01475188 is registered in ClinicalTrials.gov with Ministry of Science and Higher Education, Poland as lead sponsor.

NCT NCT01475188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01475188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regulatory Lymphocytes (Treg) in the Modulation of Allergic Inflammation in Patients Treated With Specific Immunotherapy.
Lead sponsor
Ministry of Science and Higher Education, Poland
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2007
Completion date
December 31, 2010
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunotherapy, seasonal allergic rhinitis